ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2011

Aug 11, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2011-08-08

Reporting Person: McKenney Charles (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-08	Stock Option	$0.45	A	40000	Disposed	2021-08-08	Common Stock (40000)	Direct